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ABSTRACT 
Natural products that target the DNA of cancer cells have been an 
important source of knowledge and understanding in the development of 
anticancer chemotherapeutic agents. Bleomycin (BLM) exemplifies this class of 
DNA damaging agent. The ability of BLM to chelate metal ions and effect 
oxidative damage of the deoxyribose sugar moiety of DNA has been studied 
extensively for four decades.  
Here, the study of BLM A5 was conducted using a previously isolated 
library of hairpin DNAs found to bind strongly to metal free BLM. The ability of 
BLM to effect single-stranded was then extensively characterized on both the 3′ 
and 5′-arms of the hairpin DNAs. The strongly bound DNAs were found to be 
efficient substrates for Fe·BLM A5–mediated cleavage. Surprisingly, the most 
prevalent site of damage by BLM was found to be a 5′-AT-3′ dinucleotide 
sequence. This dinucleotide sequence and others generally not cleaved by BLM 
when examined using arbitrarily chosen DNA substrate were found in examining 
the library of ten hairpin DNAs. In total, 111 sites of DNA damage were found to 
be produced by exposure of the hairpin DNA library to Fe·BLM A5. 
Also, an assay was developed with which to test the propensity of the 
hairpin DNAs to undergo double stranded DNA damage. Adapting methods 
previously described by the Povirk laboratory, one hairpin was characterized 
using this method. The results were in accordance with those previously reported. 
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Chapter 1 
AN OVERVIEW OF DNA AND BLEOMYCIN STUDIES 
DNA and Cleavage Reactions 
Friederich Miescher discovered deoxyribonucleic acid (DNA) by chance 
in 1869 while trying to identify the chemical constituents of cells. While studying 
the pus from used surgical dressings, he isolated a substance he called nuclein 
from the cellular nucleus which precipitated in acid, and was re-dissolved upon 
treatment with alkali.
1
 
Later study of DNA found that it is composed of repeating nucleotide 
units. A nucleotide of the DNA is composed of four different nucleobases: 
adenine (A), thymine (T), guanine (G) and cytosine (C). The nucleobases are 
covalently linked to a 2-deoxyribose sugar which has a pentavalent phosphate 
attached to it in the 5ʹ-position. The phosphate provides the linkage through which 
multiple nucleotides are attached in repetitive strands.
2
 The polynucleotide can 
form a double stranded structure through G:C and A:T base pairs (Figure 1.1). 
Notably, Watson and Crick determined that these polynucleotides adopted a 
double helical conformation (Figures 1.1 and 1.2). 
3
  
The double helix is formed by the binding of two DNA strands in an 
antiparallel fashion through a cooperative mechanism of π-π helical stacking and 
hydrogen bonding at the Watson and Crick faces of the DNA nucleobases (Figure 
1.1).
2
  The sugar and phosphate backbone imparts its own structural features onto 
the DNA helix, including the presence of two distinct grooves, termed minor and 
the major (Figure 1.2).
4 
 In what is thought to be the most biologically prevalent 
2 
form of DNA, B-form, the DNA has a narrow minor groove and wide a major 
groove (Figure 1.3).
4
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Figure 1.1: Base pair connections made at the Watson-Crick faces of the nucleobases, showing the 
relative orientation of sugars to each other in an antiparallel fashion. Also indicated is the way in 
which the glycosidic linkage between ribose and the nucleobase frames the minor and major 
grooves. 
 
 
Figure 1.2: A purely diagrammatic image of the DNA double helix from Watson and Crick’s 
classic 1953 publication. The ribbons represent the sugar-phosphate back bone, while the bars 
represent the hydrogen bonding of the Watson-Crick faces of the AT and GC basepairs. The center 
line marks the helical axis.
3
 
 
major groove 
minor groove 
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Figure 1.3: The different local structures adopted by the DNA double helix, from left to right: A-
DNA, B-DNA and Z-DNA.
2
 
 
DNA functions as the template for the transmission of genetic 
information.
5
 The development and study of drugs that target the DNA of cancer 
cells are of great interest as chemotherapeutic agents. Historically, some of the 
first anticancer chemotherapeutic agents were DNA damaging compounds. These 
classes of damage include alkylation, mediated by agents such a dimethyl sulfate, 
or cross-linking mustard compounds such as mechlorethamine.
6
 These agents 
damage strands by making the nucleobase itself sucesptible to hydrolysis 
(dimethyl sulfate) or providing additional strain on the DNA molecule through 
interstrand cross links. The attachment distorts the structure and allows cleavage 
of the double-helix (mechlorethamine).
6
 The compound studied in this work 
comprises part of another class of compounds which damage DNA. The family of 
glycopeptide antibiotics, the bleomycins, effect oxidative damage to the sugar of 
DNA (Figure 1.4).
 
4 
 
Figure 1.4:  The general structure of the family of BLMs, including its structural domains. The R 
groups below represent differing C-terminal substituents that are the main difference among BLM 
congeners. 
7 
 
Bleomycin Overview 
The BLMs were first isolated from a fungal broth in 1966 by Umezawa 
and coworkers as copper chelates.
8
 BLM has realized success in the treatment of 
testicular cancer
9
 and is an important part of combination therapy for non-
Hodgkin’s Lymphoma10 under the commercial name Blenoxane (Bristol-Myers 
Squib Company). Blenoxane is a mixture of BLM congeners, mainly composed 
of BLM A2 and B2 (Figure 1.4). The cytotoxicity of the drug is attributed to the 
ability of BLM to bind and degrade DNA in a sequence selective fashion at 5′-
GC-3′ and 5′-GT-3′ dinucleotide sequences.11 BLM also has the ability to bind 
and degrade RNA in a shape selective fashion.
12
 BLM can damage the DNA in 
5 
both single-stranded
11,13,14
 and double-stranded manners.
15
 The latter damage is 
thought to be the most deleterious to cells as it is more difficult to repair.
16
  
BLM requires a metal ion cofactor and oxygen to damage DNA. Analysis 
of the degradation products of DNA damage indicate that this damage is initiated 
by abstraction of the C-4ʹ H in the minor groove of the DNA (Figure 1.1).17 The 
ability of BLM to selectively bind and initiate DNA cleavage is due to the 
complex structure of the molecule. Four domains of BLM can be distinguished: 
the metal binding domain, the linker region, the DNA binding domain and the 
carbohydrate moiety (Figure 1.4).
18 
 
Structural Domains of Bleomycin 
The metal binding region contains the nitrogen atoms responsible for 
chelating a metal ion and activating molecular oxygen, which ultimately leads to 
DNA cleavage.
19
 According to X-ray crystallography of HOO·Co(III)·BLM A2, 
the secondary and primary amines of the β-aminoalanine moiety participate in 
Co(III) coordination, along with the N-1 atom of the β-hydroxyhistidine, the  N-5 
nitrogen as well as the amide nitrogen of the pyrimidinylpropionamide moiety 
also coordinate Co(III)·OOH (Figures 1.5 and 1.6).
20
 The ability of BLM to 
chelate metal ions, including Fe, and perform oxidative transformations on DNA 
and other small molecules draw analogies between it and enzymes such as 
cytochrome P450, which also chelates iron atoms to oxidize small molecules.
21-23
  
6 
 
Figure 1.5: A drawing of BLM A2 with structural features of the compound annotated.
24
 
 
 
Figure 1.6: The crystal structure of HOO·Co(III)·BLM B2 , detailing the ligand nitrogens.
20
 
 
7 
The pyrimidoblamic acid moiety of this region is also proposed to 
contribute importantly to DNA binding and strand selectivity. Sequence 
selectivity is thought to be due to the coordination of the N-1 nitrogen and the C-2 
amino groups of the pyrimidoblamic acid to the C-2 amino and N-3 atom of the 
guanosine 5ʹ to the Py of the 5ʹ-GPy-3ʹ cleavage site (Figure 1.7).16 Alterations of 
the pyrimidoblamic acid moiety of BLM gave congeners with differing sequence 
selectivity.
25
 Epibleomycin, for example, contains a different stereocenter at the 
carbon of the β-aminoalanine group marked with an asterisk in Figure 1.7.  The 
epibleomycin congener shows a significant increase in preference for 5ʹ-TG-3ʹ 
site selection, a reverse of the 5ʹ-PuPy-3ʹ selection rule to 5ʹ-PyPu-3ʹ.25,26 The 
Hecht laboratory noted that the strand selectivity is also enforced through this 
geometric conformation suitable to cleavage of only one dinucloetide. For 
example, the complementary sequence of a 5ʹ-GC-3ʹ is 5ʹ-GC-3ʹ. Strand 
selectivity dictates that each site requires a separate binding conformation for 
cleavage to take place.
27
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minor groove to enable strand selective cleavage. Adapted from Chen and Stubbe.
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8 
The DNA binding domain enhances the ability of the molecule to bind to 
DNA (Figure 1.4). It contains the bithiazole and C-terminal substituent. There is 
evidence that the bithiazole moiety can interact with DNA via minor groove 
binding
28,29
 or through intercalation.
30
 The C-terminal substituent varies 
depending upon the specific BLM congener. Displayed in Figure 1.4, the positive 
charge on the C-substitutent is either permanent (BLM A2) or the prevalent 
species at physiological pH (BLM B2, BLM A5). The cationic substituent may 
enhance interaction with the negatively charged DNA phosphate backbone. 
Removal of the C-terminal substituent diminishes DNA cleavage efficiency 
tenfold.
31,32
  
The linker region is thought to organize the molecule into a compact 
structure that facilitates DNA cleavage. It is composed of L-threonine and 
methylvalerate amino acids. Studies detailing the systematic modification of this 
region have shown that alterations can dramatically alter the DNA cleavage 
efficiency and ratio of double-stranded DNA damage by BLM. 
18,31,33,34
 Boger 
and colleagues found that as long as modifications of this region did not abolish 
cleavage activity the sequence selectivity was not altered. The ratio of double- 
stranded to single-stranded damage was affected, however. The presence of L-
threoine was strongly preferred over other amino acid analogues.
35
  
The carbohydrate moiety of BLM is the disaccharide 2ʹ-O-
mannopyranosyl-α-L-gulose modified at the 3ʹ-oxygen of the gulose with a 
carbamoyl group. The precise function of the disaccharride is still debated. The 
BLM aglycone functions in a similar manner to the glycosylated BLM (Figure 
9 
1.8), however the ratio of single-stranded to double-stranded cleavage is twofold 
higher for glycosylated BLM. 
36,37
 The sugar attachment also influences DNA 
recognition
38
, may aid in metal binding
39,40
 and may facilitate cellular uptake.
41
 
DNA and RNA cleavage studies have shown that the α-L-gulose is the sugar most 
responsible for cleavage potency.  Removal of the gulose yielded a BLM 
analogue that was 2-5 times less efficient at cleaving DNA than BLM A2. The 
DNA cleavage efficiency was essentially equivalent to the BLM aglycone, 
deglycoBLM (Figure 1.8).
36,42 
 
Figure 1.8: The structure of deglycoBLM A5.
7 
 
DNA Cleavage by Bleomycin 
As explained above, the intricate structure of BLM allows it bind a metal 
ion, oxygen and DNA, facilitating the abstraction of the 4′-hydrogen atom from 
the deoxyribose sugar of DNA. BLM, Fe
2+
 and oxygen combine to form a ferric 
superoxide complex: 
•
O2
-
·Fe(III)·BLM (Figure 1.9).
43
 The superoxide complex 
gains a proton and an electron to form a HOO·Fe(III) ·BLM, defined as activated 
BLM, which is the last intermediate detected prior to DNA strand scission.
44,45
 
Decker et al. recently proposed using experimental and computational analysis 
10 
that HOO•Fe(III) •BLM is responsible for abstraction of the C-4′ hydrogen atom, 
initiating DNA damage.
45 
 
 
 
Figure 1.9: Proposed catalytic cycle of Fe·BLM.
18
 
 
 Fe·BLM can effect DNA damage through two different pathways. One 
pathway produces frank strand scission
46
 and the other produces an alkali labile 
lesion.
47
 The preferred sequence selectivity, 5′-GPy-3′, results in oxidative 
damage of the pyrimidine sugar moiety resulting in the release of a base propenal 
and leaves a phosphoglycolate moiety attached to the 3′-hydroxyl group that is 5′ 
to the site of damage. The site to the 3′-side of the released base has a 5′- 
phosphate (Figure 1.10). After activated BLM acts upon the DNA, O2 can be 
attached to the sugar creating a 4′-hydroperoxydeoxyribose which undergoes a 
Criegee-type rearrangement. The resultant six-member heterocycle further 
rearranges, breaking down to produce a base propenal and a 3′-phosphoglycolate 
11 
moiety. An alternate pathway can also occur which does not consume an 
equivalent of oxygen (Figure 1.11). 
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Figure 1.10: A proposed mechanism for the oxygen dependent frank strand scission pathway that 
accounts for 
18
O labeling results.
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Figure 1.10 cont’d: A mechanism for the frank strand scission pathway which accounts for the 
incorporation 
18
O  into the ribose sugar structure.
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 Figure 1.11 presents a mechanism for the production of an alkali labile 
lesion, starting from the sugar C-4′-radical. This pathway does not require the 
incorporation of O2 to the sugar radical. After oxidation to the C-4′-radical water 
is incorporated into the five-membered ring of ribose. Rearrangement effects base 
release and a 4′-ketoaldehyde remains attached to the DNA strand. The 4′-
ketoaldehyde is in equilibrium with a 4′-hydroxyabasic site, the latter of which 
likely predominates in nature (Figure 1.11).
49
 Upon treatment with alkali this 
lesion rearranges to 2-hydroxycyclopentenone.
49
  
One molecule of BLM can effect cleavage upon a DNA molecule twice, 
resulting in double-stranded (ds)DNA damage.
51
 Double-stranded DNA damage 
is thought to be responsible for the antitumor activity associated with BLM 
treatment. Povirk and colleagues reported sequence selection rules for BLM 
induced dsDNA damage based on the observed cleavage sites of a restriction 
fragment.
52
 The first site of damage is generally a site preferred by BLM for 
damage (5′-GPy-3′) and the second site of cleavage is either straight across from 
13 
the initial site, or staggered in the 5′ direction on the opposing strand. The C-4′ 
hydrogen of the second site of damage is oriented in the opposite direction, 
requiring that BLM undergo significant reorganization of binding to cleave at the 
second site. For a 5′-GPyPy-3′ the second site of damage was usually directly 
opposite to the initial site of cleavage. If the site was 5′-GPyPu-3′, damage 
generally occurred directly opposite to the Pu site. This results in a fragment 
staggered by one base in the 5′ direction (Figure 1.12). Povirk and coworkers 
postulated that the primary site of damage must undergo the frank strand scission 
pathway in order for activated BLM to be regenerated to cleave the DNA again 
(Figure 1.10). The secondary site can follow either the oxygen dependent or 
independent cleavage pathway. The activated BLM must also reorganize 
dramatically in order to produce cleavage at the 4′ hydrogen on the opposing 
strand.
53
 At present there is no direct experimental evidence that supports this 
suggestion.  
In order for two oxidation events to take place near each other spatially 
and temporally a remarkable reactivation and reorganization of DNA–BLM 
binding must occur without dissociation. Indirectly, HOO·Co
III 
·BLM was 
observed via 2D-NMR study to bind in an intercalative mode via the bithiazole 
moiety, rotate about the axis of the bithiazole 180
o
 and rotate 117
o
 perpendicular 
to the helical axis of DNA.
54-56
 Fe·BLM was proposed to oxidize at the primary 
site and then access the other site of cleavage through this remarkable ring-flip 
mechanism (Figure 1.13).
57
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Figure 1.11: A mechanism for the production of 4′-hydroxyabasic acid. Upon treatment with alkali 
the strand is released and the structure of the sugar 3′ to the site of damage collapses to a 2-
hydroxycyclopentenone.
49,50
  
 
  
 
       ↓                                                               ↓ 
        5ʹ-G-Py-Pu-Pu-3ʹ               5ʹ-G-Py-Py-Pu-3ʹ 
        3ʹ-C-Pu-Py-Py-5ʹ               3ʹ-C-Pu-Pu-Py-5ʹ 
            ↑              ↑ 
 
Figure 1.12: The cleavage patterns produced by double-stranded DNA damage with BLM 
observed by Povirk et al.
52
 
 
 
 
 
15 
 
Figure 1.13: Stubbe model of BLM mediated double-strand DNA cleavage.
57
 
  
The Hecht laboratory has also studied another mode of dsDNA cleavage 
that does not require reorganization of BLM. Keck et al. observed double-
stranded cleavage of the Drew-Dickerson dodecamer more apposite of a minor 
groove binding agent, effecting cleavage with a 3-nt 3′ overhang,58 as opposed to 
the 5′ overhangs and blunt–ended fragments reported by the Povirk laboratory.52 
The Hecht laboratory documented 43% double-stranded cleavage.
58
 The 2D-
NMR study of the Zn·BLM–DNA complex indicated a complex where DNA 
offered both C4′-H atoms in close spatial proxmitiy to the Fe2+ in the metal 
binding domain.
58
  
 The 2001 study of the Drew-Dickerson dodecamer with BLM A2 was a 
foundational work in the study of BLM–DNA binding.58 The Hecht laboratory 
was the first to report and suggest a model where the global structure of DNA 
could be recognized by BLM and offer sites of cleavage that did not accord to the 
5′-GPy-3′ sequence selection (Figure 1.13).58 More recent studies by Hecht and 
colleagues on hairpin DNAs selected for their ability to bind BLM tightly have 
shown that the relationship between DNA binding and DNA cleavage is more 
16 
complex a relationship than previously believed.
7,59,60
 Chapter 2 discusses the 
previous studies in some detail. It also describes current progress made in the 
present work towards the study of DNA binding and DNA cleavage with strongly 
bound DNAs as substrates for damage. 
 
Figure 1.14: A stereoview looking into the minor groove of the Drew-Dickerson dodecamer 
complexed with BLM A2. The yellow and purple balls represent C4′-H atoms, while the white ball 
represents the metal center of BLM. This image indicates that the 3-nt separation places both 
hydrogens in proximity to the metal center of BLM. This facilitates dsDNA cleavage by the drug 
without reorganization.
58 
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Chapter 2 
 
CLEAVAGE SITE ANALYSIS OF STRONGLY BOUND DNA HAIRPINS 
REACTED WITH BLEOMYCIN A5 
Introduction 
The ability of BLM to bind to DNA and the ability to degrade DNA in a 
sequence selective fashion have been examined extensively, but independently of 
one another. Studies concerned with DNA damage activity focus on the end 
products of DNA cleavage. The studies concerned with DNA–binding focus on 
metalloBLMs such as Co
61,62
 and Zn.
28,63
 The relationship of these metalloBLMs 
to Fe·BLM is ambiguous, however. With few exceptions the studies also do not 
test the relationship between binding and cleavage directly. One study that did test 
the relationship directly employed Co.
64
 The applicability of the study of this 
metalloBLM to clinical use of the drug is not certain.   
The experimental conditions employed in these cleavage studies also 
present potential limitations in the application of the findings to the action of 
BLM in a clinical setting. These conditions include the high stoichiometric ratio 
of BLM to DNA and arbitrarily chosen DNA substrates. In clinical use, the 
effective dose of BLM is very low, ca. 5 µmol, and possible DNA targets are in 
vast excess.
60
 Given this ratio, one could assume that the obligatory binding step 
preceding cleavage is very selective, and few sequences are selected by BLM for 
potential cleavage. These selected sequences could be quite different from what 
has been learned from studies using arbitrarily chosen DNA sequences and high 
molar ratios of BLM to DNA. 
18 
Recently, the Hecht laboratory reported a study relating BLM binding 
directly to cleavage with Fe·BLM, which is believed to be the therapeutically 
relevant species (Figure 2.1).
59
 Briefly, strongly bound sequences were identified 
through the first step of a SELEX-type procedure. A mobile phase containing a 
library of 64-mer hairpin DNA sequences with an 8-nucleotide (nt) randomized 
region was passed over a stationary phase of resin-bound BLM A5. The strongly 
bound DNAs were collected and then were sequenced (Table 2.1). The Hecht 
laboratory then quantified the binding efficiencies of these DNAs using a 
competition assay employing a profluorescent nucleotide as a reporter 
molecule.
60,65
  
 
 
 
Figure 2.1: A scheme for generating a library of DNAs to expose to resin bound BLM A5 in order 
to capture DNAs that are strongly bound.
60,65
 
 
The competition assay involves a 16-nt hairpin DNA that contains a high 
efficiency cleavage site with a modified profluorescent DNA nucleobase at this 
preferred cleavage site (Figure 2.2). This substrate is cleaved stoichiometrically 
by Fe·BLM.
65
 Upon release of this base or base propenal by the action of 
Fe·BLM, fluorescence can be measured. The suppression of fluorescence upon 
addition of the 64-nt hairpin to the mixture would then quantitatively reflect the 
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binding preference of BLM for the 64-nt hairpin DNA, given a choice between 
the two substrates. Hecht and coworkers reported that when used in amounts 
equivalent to the 16-nt hairpin DNA substrate and Fe·BLM,  the ten DNA 
hairpins suppressed cleavage of the 16-nt modified hairpin by between 76 and 
97% (Table 2.2).
60
 In addition, Hecht laboratory performed an initial examination 
of the relationship between DNA binding and DNA damage through cleavage site 
analysis using 5ʹ-32P end labeled 64-nt hairpin DNAs and high resolution 
polyacrylamide gel electrophoresis. 
 
 
Table 2.1: The 64-nt hairpin DNAs isolated by Hecht and coworkers after the first 
step of SELEX-procedure.
60
 
 
 
                  C 
5ʹTTTAATTAATXXXXXXXXAAAAAATTTTAA   C 
3ʹAAATTAATTAXXXXXXXXTTTTTTAAAATT   C 
                                                C 
 
 
DNA 1  5ʹAGATCATG   DNA 2  5ʹCGTGACGC 
  3ʹTCTAGTAC     3ʹGCACTGCG 
 
DNA 3  5ʹTAAGTGGG   DNA 4  5ʹGAGAGGAT 
  3ʹATTCACCC     3ʹCTCTCCTA 
 
DNA 5  5ʹACAGAATA   DNA 6  5ʹCTACTAAA 
  3ʹTGTCTTAT     3ʹGATGATTT 
 
DNA 7  5ʹTACGCGCA   DNA 8  5ʹGGGTACCT 
  3ʹATGCGCGT     3ʹCCCATGGA 
 
DNA 9  5ʹCGTTGTTA   DNA 10 5ʹCGCCATTG 
  3ʹGCAACAAT     3ʹGCGGTAAC 
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Figure 2.2: Chemical structure of a 16-nt hairpin DNA-Cf15 having the 2′-deoxyriboside of 4 
aminobenzo[g]quinazoline-2-one (Cf) at position 15.
65
 
 
 
Table 2.2: The binding specificity of the hairpin DNAs as recorded from the suppression of 
cleavage by Fe·BLM A5 of a 16-nt with a profluorescent nucleotide.
60,65  
 
 
The study revealed a complex relationship between binding and cleavage. 
Many of the DNAs that are bound strongly present at least one 5ʹ-GT-3ʹ or 5ʹ-GC-
3ʹ dinucleotide sequence (Table 2.1). These sequences also appear as the 
dominant sites of damage in the high resolution polyacrylamide electrophoresis 
experiments.
60
 Other hairpins are not as strongly bound and offer no canonical 
dinucleotide sequences, but are still cleaved avidly by BLM. The wide range of 
sequence motifs and cleavage efficiencies identified in this study indicate a much 
more complex picture of BLM–DNA binding and cleavage than initially 
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presumed from studies employing arbitrary DNA sequences with BLM in 
stoichiometric excess. 
The analysis of these hairpin DNAs was continued with another study by 
Giroux and Hecht detailing the interaction and chemistry of the hairpin DNAs 
with BLM A5 and deglycoBLM A5 (Figure 1.8).
7
 This study showed that 
deglycoBLM A5 cleaved the hairpins in a manner similar to BLM A5, although in 
diminished potency. Interestingly, deglycoBLM A5 produced DNA damage on 
the hairpin DNAs that appeared only in the oxygen independent pathway, whereas 
BLM A5 did not.
7
 The present work builds on this study, providing a 
comprehensive picture of DNA cleavage by Fe·BLM A5 by using both 5′ and 3′-
32
P end labeling to fully characterize all sites of cleavage inflicted on these 
specially selected hairpin DNAs by BLM A5. 
This work then further characterizes the DNAs for their propensity to be 
cleaved twice by one molecule of BLM (double-stranded cleavage). Adapting 
methodologies from the Hecht
58
 and Povirk
52
 laboratories to examine the hairpin 
DNAs, an assay was developed for the initial examination of double-stranded 
(ds)DNA damage. Application of this method to the current library of 10 hairpin 
DNAs would then provide insights into the relationship between binding and 
dsDNA damage. Plausibly, the effectiveness of BLM is due to its ability to 
identify specific sequences for cleavage and damage both DNA strands in a single 
process, thereby explaining its exceptional antitumor potency.   
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Results 
 The recently reported library of hairpin DNAs, of the form 5′-
TTTAATTAATXXXXXXXXAAAAAATTTTAACCCCTTAAAAT 
TTTTTYYYYYYYYATTAATTAAA-3′, were characterized by high resolution 
polyacrylamide electrophoresis and the cleavage suppression of a previously 
studied 16-nt hairpin with a pro-fluorescent hairpin DNA.
60
 The hairpin DNAs 
were collected via the first step of a SELEX-type procedure to provide hairpin 
DNA sequences that are strongly bound by metal free BLM A5. These hairpin 
DNAs were found to inhibit cleavage from 76% to 97%. The following results 
describe analysis of cleavage of the 10 hairpin DNAs by denaturing 
polyacrylamide gel electrophoresis using  5ʹ and 3′-32P  end labeling, allowing for 
the analysis of every site cleaved by Fe(II)·BLM A5 in the hairpin DNA library. 
 DNA 1 was treated with increasing concentrations Fe(II)·BLM A5 and 
several strong cleavage sites were observed in both 5ʹ and 3ʹ-32P end labeling. 
Figure 2.3A
60
 (gel performed by Dr. Qian Ma) clearly shows the presence of six 
cleavage sites. None of these sites follow the canonical dinucleotide cleavage sites 
for BLM A5. These sites include A9, T10 A13, T14 , and A19.  There are several 
unusual sites and sequence motifs worthy of note, namely the 5ʹ-PuPu-3ʹ cleavage 
sites at 5ʹ-GA9-3ʹ, 5ʹ-GA13-3ʹ and 5ʹ-GA19-3ʹ. The other nucleobase cleaved on 
this hairpin, thymidine, follows the more classic motif of 5ʹ-PuPy-3ʹ. The purine 
was not the usual guanosine, but adenine. These dinucleotide sequences were 5ʹ-
AT10-3ʹ, 5ʹ-AT14-3ʹ and 5ʹ-AT17-3ʹ. 
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Figure 2.3:  A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 1 by BLM 
A5. Lane 1, radiolabeled 1 alone; lane 2, 20 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 5 μM Fe(II) 
·BLM A5; lane 5, 20 μM BLM A5; lane 6, 20 μM Fe(II) ·BLM A5; lane 7, G-lane.
10
 B) Sequence-
selective cleavage of [3′-32P] end labeled 64-nt hairpin DNA 1 by BLM A5. Lane 1, radiolabeled 1 
alone; lane 2, 10 μM Fe2+; lane 3, 10 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; lane 5, 5 μM 
Fe(II) ·BLM A5; lane 6, 10 μM Fe(II) ·BLM A5; lane 7, G-lane.  
  
 
A) B) 
                                  C 
5'TTTAATTAAT AGATCATG AAAAAATTTTAA  C 
3'AAATTAATTA TCTAGTAC TTTTTTAAAATT  C 
                                  C 
1   2   3     4    5    6    7 
T49 
T52 
A51 
T56 
T57 
A59 
T60 
T61 
1   2   3    4   5   6   7 
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The 3ʹ-32P end labeling cleavage experiment (Figure 2.3B) of DNA 1 
showed very similar results to Figure 2.3A, as the hairpin contained no classically 
cleaved dinucleotide sequences for Fe(II)·BLM A5, but did contain several strong 
sites for cleavage, which were close to the radiolabel. The sites T49, A51, T52, T56, 
T57, A59, T60 and T61 were cleaved by BLM A5 at the 3ʹ-arm of the hairpin DNA. 
The very strong site at T56 is actually within the flanking region of the hairpin 
DNA. This site is a 5ʹ-AT-3ʹ site, similar to the sites found on the 5ʹ- arm of the 
hairpin DNA. However there was also a very unusual 5ʹ-TT-3ʹ cleavage band, 
which albeit weak, is generally not reported in the literature that has employed 
arbitrarily chosen DNA substrates. 
DNA 2 differed from DNA 1 at the 5ʹ-arm of the hairpin DNA. DNA 2 
contained two traditionally cleaved dinucleotide sequences (5ʹ-GC-3ʹ). Although 
there was cleavage at these sites, it was cleaved comparatively weakly to the other 
classic cleavage motif of 5ʹ-GT-3ʹ which represented the strongest site of cleavage 
(Figure 2.4A, performed by Dr. Qian Ma).
60 
 DNA 2 also had a binding efficiency 
of 97%, which is the highest value recorded in the competition assay.  The lesion 
at A15 is a 5ʹ-PuPu-3ʹ dinucleotide sequence motif. It was cleaved quite weakly in 
comparison to both the classic cleavage motifs.  This 5ʹ-32P end labeled 
experiment also did not demonstrate the presence of cleavage in the flanking 
regions as definitively as the 3′-32P end labeled hairpin DNA 1.  
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Figure 2.4: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 2 by BLM 
A5. Lane 1, radiolabeled 2 alone; lane 2, 20 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 5 μM Fe(II) 
·BLM A5; lane 5, 20 μM BLM A5; lane 6, 20 μM Fe(II) ·BLM A5; lane 7, G+A lane; lane 8, G-
lane. B) Sequence-selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 2 by BLM A5. 
Lane 1, radiolabeled 2 alone; lane 2, 10 μM Fe2+; lane 3, 10 μM BLM A5; lane 4, 1 μM Fe(II) 
·BLM A5; lane 5, 5 μM Fe(II) ·BLM A5; lane 6, 10 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
 
 
A) A) 
                                  C 
5'TTTAATTAAT CGTGACGC AAAAAATTTTAA  C 
3'AAATTAATTA GCACTGCG TTTTTTAAAATT  C 
                                  C 
1    2   3     4    5   6   7 
T45 
C47 
T49 
A54 
1    2   3  4  5  6   7 8 B) 
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 The 3ʹ-32P end labeled hairpin DNA 2 contained two classically cleaved 
dinucleotide sequences. The most preferred of these was 5ʹ-GT49-3ʹ (Figure 2.4B). 
These two dinucleotide sequences represented the strongest sites of cleavage. 
There were two very weak cleavages at T45 and A54, including a rarely reported 
5ʹ-PyPy-3ʹ sequence motif. Work by Ma et al. reported the binding specificity of 
DNA 2 as 97%, which was markedly higher than that of DNA 1 (82%). It is of 
interest to note that the number of cleavage sites was less on both arms of the 
hairpin DNA for DNA 2 compared to DNA 1. 
 Hairpin DNA 3 provided very interesting cleavage results despite its 
comparatively low binding specificity reported by the Hecht laboratory in 2009 as 
76%.
60
 The hairpin sequence contains four G:C base pairs, and only one 5ʹ-GPy-3ʹ 
site, which was cleaved, but with an intensity similar to that of the other sites on 
the 5ʹ-32P end labeled arm (Figure 2.4A, performed by Qian Ma).60 The 5ʹ-arm 
was cleaved six times at the sites A8, A9, T10, A12, T15 and A19. A 5ʹ-PyPu-3ʹ 
cleavage site at T10 was the strongest relative site of cleavage on this arm of the 
hairpin DNA.  Radiolabeling the 5′-arm provided a comparable number of 
cleavage sites compared to DNA 1, with six, while the 3ʹ-arm of  hairpin DNA 3 
showed a substantially different result. 
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Figure 2.5: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 3 by BLM 
A5. Lane 1, radiolabeled 3 alone; lane 2, 20 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 5 μM Fe(II) 
·BLM A5; lane 5, 20 μM BLM A5; lane 6, 20 μM Fe(II) ·BLM A5; lane 7, G-lane.
60
 B) Sequence-
selective cleavage of [3′-32P] end labeled 64-nt hairpin DNA 3 by BLM A5. Lane 1, radiolabeled 3 
alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; lane 5, 2.5 μM 
Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, C-lane. 
 
 
1   2   3  4  5   6   7 1   2   3   4   5    6   7 
A) B) 
                                  C 
5'TTTAATTAAT TAAGTGGG AAAAAATTTTAA  C 
3'AAATTAATTA ATTCACCC TTTTTTAAAATT  C 
                                  C 
T47 
T56 
T57 
A59 
T60 
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 Hairpin DNA 3 was cleaved at T46, T56, T57, A59, and T60 when 3′-
32
P end 
labeled (Figure 2.5B). The strongest cleavage sites occurred at T56 and T60. There 
were no clear amounts of cleavage within the randomized region, as opposed to 
the cleavage that appeared on the 5ʹ-32P end labeled hairpin DNA 3. This 
preference to cleave the 5′-arm is of special note as hairpin DNA 3 was the only 
example of the hairpin DNAs tested that demonstrated no clear cleavage in the 
randomized region when the 3′-arm was 32P-end labeled. 
 Hairpin DNA 4 (5ʹ-32P end labeled) is shown in Figure 2.6A 
(polyacrylamide gel performed by Qian Ma).
60
 The reported binding specificity of 
this hairpin DNA was 79%, which is relatively low compared to the other hairpin 
DNAs. It does not contain any classic sequence motifs for cleavage, but showed a 
comparatively strong cleavage site at 5ʹ-GA12-3ʹ. The other sites occurred at T9, 
T10, A14, A17 and T18. These sites are all 5ʹ-PuPy-3ʹ sequence motifs, excepting 
A17 which is a 5ʹ-PuPu-3ʹ sequence. Similar to hairpin DNA 3, there was a 
divergence in the cleavage that was observed for BLM A5 on the opposing arm. 
 The 3ʹ-32P end labeled hairpin DNA 4 showed cleavage at three sites, all 
of which are thymidines, namely at T48, T53 and T56 (Figure 2.6B). The 3′-arm 
showed fewer cleavage sites, but comparatively similar amounts of cleavage. 
There was no appreciable cleavage in the flanking region. This sequence 
composition was similar to that offered by hairpin DNA 3 which also showed a 
similar divergence in the number of cleavage sites on alternate arms of the hairpin 
DNA, but both hairpin DNAs shared similar binding specificities. 
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Figure 2.6: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 4 by BLM 
A5. Lane 1, radiolabeled 4 alone; lane 2, 20 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 5 μM Fe(II) 
·BLM A5; lane 5, 20 μM BLM A5; lane 6, 20 μM Fe(II) ·BLM A5; lane 7, G-lane.
60
 B) Sequence-
selective cleavage of [3′-32P] end labeled 64-nt hairpin DNA 4 by BLM A5. Lane 1, radiolabeled 4 
alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; lane 5, 5 μM 
Fe(II) ·BLM A5; lane 6, 10 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
 
A) B) 
                                  C 
5'TTTAATTAAT GAGAGGAT AAAAAATTTTAA  C 
3'AAATTAATTA CTCTCCTA TTTTTTAAAATT  C 
                                  C 
1    2    3    4   5  6   7 
T48 
T53 
T56 
1    2    3    4   5   6   7 
30 
BLM A5 cleaved hairpin DNA 5 at thirteen sites on the 5′-arm. Hairpin 
DNA 5, remarkably, contains no 5′-GPy-3′ dinucleotide sequences on its 5′–arm 
either (Figure 2.7A). DNA 5 was cleaved at the most sites of any hairpin DNA in 
this library of strongly bound hairpin DNAs, but the binding specificity of 90% 
was not the highest measured by Ma et al.
60
 The sites of cleavage included 5′-
TT7-3′, 5′-TA9-3′ and 5′-AA10-3′ inside the flanking region, while relatively 
strong cleavage occurred at 5′-GA15-3′ in the randomized region of the hairpin. 
The other sites cleaved by BLM A5 all follow unusual sequence specificities, and 
the DNA was cleaved many times. 
The 3′-arm of the hairpin DNA 5 was cleaved in a very similar manner to 
the 5′-arm. The 5′-GT54-3′ was the preferred site of cleavage, which was 
consistent with the expected cleavage pattern for BLM (Figure 2.7B). Thirteen 
other sites were also cleaved by BLM, albeit relatively weakly. A noteworthy site 
of unusual cleavage, 5′-TG53-3′, follows the unusual sequence selective pattern of 
a 5′-PyPu-3′. In summary, hairpin DNA 5 was cleaved avidly by Fe·BLM A5 
within and without the randomized region of the hairpin DNA on both arms. 
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Figure 2.7: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 5 by BLM 
A5. Lane 1, radiolabeled 5 alone; lane 2, 20 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 5 μM Fe(II) 
·BLM A5; lane 5, 20 μM BLM A5; lane 6, 20 μM Fe(II) ·BLM A5; lane 7, G+A lane. B) Sequence-
selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 5 by BLM A5. Lane 1, radiolabeled 5 
alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; lane 5, 5 μM 
Fe(II) ·BLM A5; lane 6, 10 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
                                  C 
5'TTTAATTAAT ACAGAATA AAAAAATTTTAA  C 
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Hairpin DNA 6 also lacked any dinucleotide sequences commonly cleaved 
strongly by Fe·BLM. The binding efficiency of this DNA was also lower, 82% 
(Figure 2.8A).  Despite this, DNA 6 still underwent cleavage at seven sites on its 
5′-arm, including the unusual 5′-AC14-3′ and 5′-CT15-3′ sites in the randomized 
region of the hairpin. The flanking region, near the radiolabel was cleaved at more 
sites than the randomized region. These sites included 5′-AA5-3′, 5′-AT6-3′ and 
5′-TT7-3′. The sites A9 and T10 were also cleaved. Interestingly, the 5′-TA8-3′ was 
not cleaved on this hairpin DNA. 
 Figure 2.8B shows the cleavage sites on the 3′-arm of hairpin DNA 6. 
There were fewer sites available to BLM on this side of the hairpin DNA, with 
only one site of cleavage in the randomized region of the hairpin DNA (5′-AT52-
3′). The rest of the cleavage occurred in the randomized region at A55, T56, A58 
and T59. To summarize, this hairpin DNA was cleaved at 12 sites on both arms 
and each one was a dinucleotide sequence usually not cleaved by BLM A5. The 
relative paucity of cleavage on this hairpin DNA compared to DNA 5 is notable, 
and perhaps can be explained by the lower binding specificity of this DNA. 
Sequence selective cleavage of DNA 7 is presented in Figure 2.9. The 5′-
arm of hairpin DNA 7 is presented in Figure 2.9A. Hairpin DNA 7 was bound 
exceptionally well by BLM A5, with a measured value of 97% in the binding 
specificity assay, the highest recorded value in the assay. Except for two sites at 
A9 and T10, the hairpin 7 was cleaved all within the randomized portion of the 
DNA. The only nucleotides not cleaved were G14 and G16. The hairpin contains 
two 5′-GC-3′ dinucleotide sequences. The 5′-GC17-3′ dinucleotide sequence was 
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the preferred site of cleavage on the 5′-arm of hairpin DNA 7. Remarkably, the 5′-
GC15-3′ site was not cleaved to any degree beyond that of the other sites of 
cleavage. 
The 3′-arm of hairpin DNA 7 differed from the 5′-arm in respect to 
distribution of cleavage sites; most of the cleavage sites occurred in the flanking 
region of DNA 7 (Figure 2.9B). This preference is interesting to note because of 
the presence of three 5′-GPy-3′ cleavage motifs in the randomized region. Of the 
three sites, two were cleaved: 5′-GC51-3′ and 5′-GT53-3′. The lack of cleavage at 
5′-GC49-3′ is notable. The 5′-GT53-3′ site was the most efficiently cleaved site on 
the 3′-arm of this hairpin. To conclude, BLM A5 cleaved DNA 7 at 15 sites and 
had the highest binding efficiency measured (97%). Interestingly, BLM A5 
preferred certain 5′-GPy-3′ dinucleotide sites over others, with 5′-GT-3′ being the 
most efficiently cleaved, and certain other sites (5′-GC51-3′) not undergoing 
cleavage. 
The binding specificity of hairpin DNA 8 was 92%. The 5′-arm contained 
four sites of cleavage, including a strong site at 5′-GT14-3′ (Figure 2.10A). The 
other sites were cleaved weakly in comparison, including sites at dinucleotide 
sequences 5′-AT10-3′, 5′-GG12-3′ and 5′-TA15-3′. The 5′-GG12-3′ is very 
interesting, representing one of the few sites of cleavage at a G residue and one of 
only two recorded 5′-GG-3′ cleavage sites within the library of hairpin DNAs. 
The 3′-arm of the hairpin DNA also had a site of cleavage at a 5′-GT-3′ 
dinucleotide sequence, but the 3′-arm also contained several cleavage sites in the 
flanking region of the hairpin DNA. 
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Figure 2.8: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 6 by BLM 
A5. Lane 1, radiolabeled 6 alone; lane 2, 5 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) 
·BLM A5; lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. B) 
Sequence-selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 6 by BLM A5. Lane 1, 
radiolabeled 6 alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; 
lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
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Figure 2.9: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 7 by BLM 
A5. Lane 1, radiolabeled 7 alone; lane 2, 5 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) 
·BLM A5; lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. B) 
Sequence-selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 7 by BLM A5. Lane 1, 
radiolabeled 7 alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; 
lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
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The hairpin DNA 8 was cleaved six times on the 3′-arm of the hairpin 
DNA (Figure 2.10B). The strongest site of cleavage was at the 5′-GT50-3′ 
dinucleotide sequence. Weaker sites included a site in the randomized region at 
5′-AC52-3′, and several sites in the invariant region: 5′-AT56-3′, 5′-TT57-3′, 5′-
AA59-3′ and 5′-AT60-3′. This hairpin DNA contains 5′-GPy-3′ dinucleotide 
sequence per arm and they both represented the strongest site of cleavage on each 
arm of the hairpin DNA. The high binding specificity (97%) and relative paucity 
of preferred binding sites represent a notable example of binding and cleavage 
preference for BLM A5. 
The BLM-mediated cleavage sites resolved by 5′-32P end labeling of hairpin DNA 
9 are presented in Figure 2.11A. There were two cleaved dinucleotide sequences 
in the randomized region, both following the preferred sequence composition of 
BLM. The cleavage sites occurred at 5′-GT13-3′ and 5′-GT16-3′, with the former 
cleaved more extensively. Two other cleavage sites occurred in the invariant 
region at A9 and T10. 
 The randomized region of the 3′-arm of the hairpin DNA contained no 
canonical dinucleotide sequences for cleavage by BLM (Figure 2.11B). The 
strongest site of cleavage was the 5′-GA55-3′ sequence. The 3′-arm of the hairpin 
DNA also showed stronger cleavage in the randomized region of the hairpin DNA 
than the 5′-arm. In summary, hairpin DNA 9 was bound with a specificity of 89% 
and cleaved a total of 11 times, including sites on both 3′ and 5′-arms of the 
hairpin DNA.  
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Figure 2.10: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 8 by BLM 
A5. Lane 1, radiolabeled 8 alone; lane 2, 5 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) 
·BLM A5; lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G lane.                          
B) Sequence-selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 8 by BLM A5. Lane 1, 
radiolabeled 8 alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; 
lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
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The site specific cleavage of 5′-32P end labeled DNA 10 is presented in 
Figure 2.12A.  BLM utilized five sites for cleavage on the 5′-arm of DNA 10 
including 5′-AT10-3′, 5′-GC13-3′, an interesting 5′-CC14-3′ dinucleotide sequence, 
as well as a 5′-TT17-3′ and 5′-GA19-3′. The 5′-CC-3′ dinucleotide sequence was 
not observed on any other hairpin DNA in this library, but it was cleaved 
inefficiently. The 5′-GC13-3′ dinucleotide sequence represented the dominant 
cleavage site, as has been seen regularly on the hairpin DNAs that contain a 
cleavage site classically associated with Fe·BLM cleavage. Little cleavage was 
observed in the flanking region of this DNA, compared to other DNAs such as 
DNA 1 and 7, which had considerable levels of cleavage compared to that within 
the randomized nucleotide sequence.  The hairpin DNA 10 also had a comparable 
binding specificity to DNA 5, but did not have sites preferred by BLM for 
cleavage. The lack of cleavage sites on the 5′-arm of the hairpin is contrasted by 
the eleven sites observed within the 3′-arm. 
Similar to the 5′-arm, the 3′-arm had one canonical site of cleavage at 5′-
GC53-3′. This site and a variety of other sequence motifs were cleaved with 
comparable efficiency, including cleavage at 5′-GG52-3′. There were four 
cleavage sites in the randomized region, but seven cleavage sites in the invariant 
region were observed for hairpin DNA 10. For many of the 10 hairpin DNAs 
treated with BLM in this study, there was a difference between cleavage sites on 
the 5′- and 3′-arms. 
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Figure 2.11: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 9 by BLM 
A5. Lane 1, radiolabeled 9 alone; lane 2, 5 μM Fe
2+
; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) 
·BLM A5; lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G lane.                          
B) Sequence-selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 9 by BLM A5. Lane 1, 
radiolabeled 9 alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; 
lane 5, 2.5 μM Fe(II)·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
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Figure 2.12: A) Sequence-selective cleavage of [5′-32P]-end labeled 64-nt hairpin DNA 10 by 
BLM A5. Lane 1, radiolabeled 10 alone; lane 2, 5 μM Fe
2+
;lane 3, 5 μM BLM A5; lane 4, 1 μM 
Fe(II) ·BLM A5; lane 5, 2.5 μM Fe(II) ·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G lane.                          
B) Sequence-selective cleavage of [3′-32P]-end labeled 64-nt hairpin DNA 10 by BLM A5. Lane 1, 
radiolabeled 10 alone; lane 2, 10 μM Fe2+; lane 3, 5 μM BLM A5; lane 4, 1 μM Fe(II) ·BLM A5; 
lane 5, 2.5 μM Fe(II)·BLM A5; lane 6, 5 μM Fe(II) ·BLM A5; lane 7, G+A lane. 
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Each hairpin differed in cleavage sites; however, the statistical analyses of 
cleavage sites mediated by BLM on the hairpin DNA library showed that, in the 
aggregate, the 3′ and 5′-arms had a similar number of cleavage sites between A5 
and A19. The 15-nt range represented the extreme positions of BLM-mediated 
cleavage on the hairpin DNAs when 5′-32P end labeled. Table 2.3 shows the 
number of cleavages and at which dinucleotide sequence the cleavages occurred 
on the 5′-arm. The data in Tables 2.4 shows the number of dinucleotide cleavages 
available and the percentage at which they were cleaved on the 5′-arm. The most 
prevalent dinucleotide sequence cleaved in this region was 5′-AA-3′, occurring 28 
times. However, it was only cleaved 36% of the time. The most cleaved 
dinucleotide sequence was 5′-AT-3′. BLM mediated cleavage at this sequence 
56% of the time it occurred within the specified sequence range on the 5′-arm of 
the hairpin DNA. Interestingly, preferred sequences nine preferred sequences of 
cleavage (5′-GPy-3′) were selected 100% of the time. The 5′-GA-3′ was also 
cleaved every time it appeared within the sequence space specified on the 5′-arm.  
On the 3′-arm of the hairpin DNA library, the range of BLM mediated 
cleavage spanned T46 to T61, inclusively (Tables 2.5 and 2.6). BLM mediated 
cleavage on the 3′-arm showed more efficient cleavage at 5′-AT-3′ dinucleotide 
sequences, but surprisingly lower efficiency at a canonical dinucleotide sequence 
preferred for cleavage by BLM. Dinucleotide sequence 5′-GC-3′ appeared four 
times and was subject to BLM mediated cleavage three times (75% cleavage 
efficiency). Dinucleotide sequences 5′-GT-3′ and 5′-GA-3′ were cleaved each 
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time they occurred within the sequence space on the 3′-arm as recorded for the 5′-
arm of the hairpin DNAs. 
 
Table 2.3: DNAs 1-10 are summarized by the dinucleotide sequences cleaved by BLM A5 in a 5′-
32
P end labeled cleavage assay. The total number of cleavages per DNA is shown on the right hand 
side, which is then totaled at the bottom. 
5′-XX-3′ DNA Hairpins 
 
 
1 2 3 4 5 6 7 8 9 10 total 
AA 1 1 1 1 1 1 1 
 
1 2 10 
AC 
    
1 1 1 
   
3 
AG 
          
0 
AT 3 1 1 2 1 1 1 1 1 2 14 
CA 
      
1 
   
1 
CC 
         
1 1 
CG 
          
0 
CT 
     
1 
    
1 
GA 2 1 1 3 1 
    
1 9 
GC 
 
1 
    
2 
  
1 4 
GG 
       
1 
  
1 
GT 
 
1 1 
    
1 2 
 
5 
TA 
  
2 
   
1 1 
  
4 
TC 
          
0 
TG 
          
0 
TT 
    
1 1 
   
1 3 
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In summary, on both 3′ and 5′-arms, 5′-AT-3′ dinucleotide was the most 
often cleaved site. This site is generally not preferred for cleavage by BLM, but 
this library of hairpin DNAs contains many AT sequences, which BLM cleaved 
roughly 65% of the time the dinucleotide sequence appeared on both 3′ and 5′-
arms. There were 111 sites of cleavage on these 10 hairpins including both the 3′ 
and 5′-arms, approximately one third of which were 5′-AT-3′ dinucleotide 
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sequences. Interestingly, the 5′-AG-3′ dinucleotide sequence was not cleaved at 
all in this library of 10 hairpin DNAs. Although this does not necessarily indicate 
that this sequence cannot be cleaved, finding a hairpin DNA where the sequence 
5′-AG-3′ is cleaved would be interesting in that it would enable an understanding 
of the surrounding sequence composition permitting cleavage at that position.  
 
Table 2.4: The number of times a dinucleotide sequences appears on the 5′-arm of a hairpin 
between A5 and A19, inclusively. This sequence space represents the extreme range of BLM 
mediated cleavage on the 5′-arm of the hairpin DNA.  
5′-XX-3′ DNA Hairpin   
    1 2 3 4 5 6 7 8 9 10 Occurrences Cleavages Percent cleaved 
AA  2 2 3 2 4 5 3 2 3 2 28 10 36% 
AC 
 
1 
  
1 1 1 1 
  
5 3 60% 
AG 1 
 
1 2 1 
     
5 0 0% 
AT 4 2 2 3 3 2 2 2 2 3 25 14 56% 
CA 1 1 
  
1 
 
1 
  
1 5 1 20% 
CC 
       
1 
 
1 2 1 50% 
CG 
 
2 
    
2 
 
1 1 6 0 0% 
CT 
     
2 
 
1 
  
3 1 33% 
GA 2 1 1 3 1 
    
1 9 9 100% 
GC 
 
1 
    
2 
  
1 4 4 100% 
GG 
  
2 1 
   
2 
  
5 1 20% 
GT 
 
1 1 
    
1 2 
 
5 5 100% 
TA 2 1 2 2 3 3 2 3 2 1 21 4 19% 
TC 1 1 
   
1 
  
1 1 5 0 0% 
TG 1 1 1 1 
   
1 1 1 7 0 0% 
TT 1 1 2 1 1 1 2 1 3 2 15 3 20% 
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Table 2.5: DNAs 1-10 are summarized by the dinucleotide sequences cleaved by BLM A5 in a 3′-
32
P end labeled cleavage assay. The total number of cleavages per DNA is shown on the right hand 
side, which is then totaled at the bottom. 
 5′-XX-3′ Hairpin DNA  
 
 
1 2 3 4 5 6 7 8 9 10 total 
AA 1 
 
1 
   
1 
 
3 2 8 
AC 
       
1 
  
1 
AG 
          
0 
AT 4 
 
2 1 2 2 2 1 2 3 19 
CA 
          
0 
CC 
          
0 
CG 
          
0 
CT 
   
2 
      
2 
GA 1 1 
   
1 
  
1 1 5 
GC 
 
1 
    
1 
  
1 3 
GG 
         
1 1 
GT 
 
1 
  
1 1 1 1 
  
5 
TA 
         
1 1 
TC 
          
0 
TG 
          
0 
TT 2 1 2 
   
2 
 
1 2 10 
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DsDNA damage mediated by BLM on the Hairpin DNA Library 
The characterization of dsDNA damage has been an important priority in 
BLM studies due to the belief that it may be the mechanism through which BLM 
exerts its cytotoxicity. The Povirk laboratory was the first to present rules for this 
cleavage, which are described in Chapter 1. In order to characterize this hairpin 
DNA library for its propensity to undergo dsDNA cleavage by BLM A5, the 
method of native polyacrylamide gel analysis followed by sequencing at putative 
dsDNA damage sites on a denaturing gel was employed. In order to provide proof 
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of concept for this method when applied to the hairpin DNAs, DNA 8 was first 
subjected to this method of characterization. DNA 8 contains a well known self 
complementary d(GTAC)2 sequence which is a studied, high efficiency site for 
dsDNA cleavage by BLM.
66
 
 
Table 2.6: The number of times a dinucleotide sequences appears on the 3′-arm of a hairpin 
between T46 and T61, inclusively. This sequence space represents the extreme range of BLM 
mediated cleavage on the 3′-arm of the hairpin DNAs. 
 5′-XX-3′ Hairpin DNA        
  1 2 3 4 5 6 7 8 9 10 occurrences cleavages 
percent 
cleaved 
AA  1 1 2 1 1 1 2 1 3 2 15 8 53% 
AC - 1 1 - - - - 1 2 - 5 1 20% 
AG - - - - - 2 - 1 - - 3 0 0% 
AT  4 2 2 3 4 2 2 2 2 3 26 19 73% 
CA 1 1 1 1 
   
1 1 1 7 0 0% 
CC 
  
2 1 
   
2 
  
5 0 0% 
CG 
 
2 
    
2 
 
1 1 6 0 0% 
CT 1 
 
1 2 1 
     
5 2 40% 
GA 1 1 
   
1 
  
1 1 5 5 100% 
GC 
 
1 
    
2 
  
1 4 3 75% 
GG 
       
1 
 
1 2 1 50% 
GT 
 
1 
  
1 1 1 1 
  
5 5 100% 
TA   2 1 2 2 3 3 2 3 2 1 21 1 5% 
TC 2 1 1 3 1 
    
1 9 0 0% 
TG 1 1 
  
1 
 
1 
  
1 5 0 0% 
TT   3 3 4 3 4 6 4 3 4 3 37 10 27% 
 
 
Figure 2.13 displays the results of treating 5′ and 3′-32P end labeled hairpin 
DNA 8 and separating the reaction mixture on a native polyacrylamide gel. Both 
the A and B bands comigrated, and the weaker lower running C and D bands also 
comigrated (Figure 2.13). These bands were both excised from the 
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polyacrylamide and electrophoresed on a denaturing gel with a sequencing ladder 
to characterize the sites of damage. Figure 2.14 shows plainly that d(GTAC) 
sequence was indeed cleaved in dsDNA fashion by BLM at T14 and T50 and 
produced a 5′-extension on the 3′-arm of the hairpin DNA, according to 
electrophoresis of spots A and B, respectively. These results are consistent with 
the results published previously, 
67
 and indicate that this method can be applied to 
the hairpin DNA library for characterizing the sequences putatively cleaved twice 
by one molecule of Fe·BLM A5. 
 
 
Figure 2.13: Cleavage products of DNA 8 resolved by native polyacrylamide electrophoresis.  
Lanes 1 – 3 contain [3′-32P]-end labeled 64-nt hairpin DNA 8. Lanes 4 – 6 contain [5′-32P]-end 
labeled 64-nt hairpin DNA 8.   Lane 1, [3′-32P]-end labeled 64-nt hairpin DNA 8 alone; lane 2, 1.5 
µM Fe(II)∙BLM A5; lane 3, Fe(II)∙BLM A5 3.0 µM; lane 4, [5′-
32
P]-end labeled 64-nt hairpin 
DNA 8 alone; lane 5, 1.5 µM Fe(II)∙BLM A5; lane 6, Fe(II)∙BLM A5 3.0 µM 
 
 
 
 
 
    1        2       3     4      5       6 
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Figure 2.14: Denaturing polyacrylamide electrophoresis of spots A, B, C and D from the gel 
pictured in Figure 2.13. Lane 1, spot A; lane 2, spot C; lane 3, [5′-32P]-end labeled 64-nt hairpin 
DNA 8 G+A lane; lane 4, spot B; lane 5, spot D; lane 6, [3′-32P]-end labeled 64-nt hairpin DNA 8 
G+A lane. The purple arrows indicate linked cleavage events. 
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Discussion 
 Bleomycin has been studied extensively for several decades, and has been 
in clinical use for nearly as long. Even so, many facets of the action of BLM are 
not completely understood, as evidenced by the present study and the 
foundational works preceding it.
7,60
 The relationship between DNA binding of 
BLM and its cleavage of DNA was examined using a specially identified library 
of 64-nt hairpin DNAs which were selected from a random hairpin DNA library 
via a SELEX-type procedure. This library provides a sequence space of 65, 536 
possible combinations.
60
 The present work differs from previous studies in other 
laboratories, which have used arbitrarily chosen DNA substrates in reactions with 
BLM at high BLM:DNA ratios. The experimental conditions applied in the 
aforementioned studies are inconsistent with the clinical administration of the 
drug. It is used in treatment in amounts where the concentration of DNA present 
is far in excess of BLM.  
The present study has characterized 10 of these DNAs using both 3ʹ and 5ʹ 
-
32
P end labeling to permit measurement of the cleavage sites from the entirety of 
the hairpin DNAs 1-10 with BLM. The goal is to identify DNA sequence 
elements preferred for cleavage in substrates strongly bound by BLM to analyze 
the obligatory binding step that occurs before C-4ʹ H abstraction.  Study of the 
hairpin DNAs through cleavage site analysis has shown that they are all substrates 
for BLM cleavage, although some were cleaved more avidly than others. The 
hairpin DNAs also showed sites of cleavage that are not traditionally found in 
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DNA cleavage reactions with BLM, including cleavage in the AT-rich invariant 
regions of the hairpin DNA.  
Overall, the 10 DNAs contained 111 sites that could be cleaved by BLM, 
while the amount of cleavage per DNA molecule varied from three sites on DNA 
8 (Figure 2.10A) to 15 on DNA 5 (Figure 2.7B), in 5′ and 3′-32P end labeling 
experiments, respectively. Hairpin DNAs 3 (Figure 2.5) and 4 (Figure 2.6) 
differed in the amounts and relative intensities of cleavage sites between their 5ʹ 
and 3ʹ-arms. Hairpin DNA 3 perhaps offered the most interesting results: the 5ʹ-
arm contained six cleavage sites that only became apparent at 20 µM 
concentration of Fe·BLM A5 (Figure 2.5B).  The 3ʹ-arm showed no cleavage 
inside the randomized region and a small amount of cleavage at sites not usually 
cleaved by Fe·BLM in the invariant flanking AT-rich sequence regions. 
Considering the low binding specificity (76%), the lack of cleavage in the 
randomized region indicates BLM–DNA binding is an important determinant of 
cleavage efficiency. DNA 4 also supports the importance of binding specificity in 
determining the number of DNA sites cleaved and the efficiency of DNA 
cleavage. 
DNA 4 showed a similar result, a cleaved 5ʹ-arm with a G-rich sequence, 
but no canonical cleavage motifs (Figure 2.6A). Even still, the DNA is cleaved 
more strongly and at more sites than on the 3ʹ-arm, which is pyrimidine rich. The 
coincident lack of 3ʹ-arm cleavage sites and relatively low binding specificity 
indicate that BLM binding preference can be dictated by the sequence of one 
strand in a DNA duplex, and comparable cleavage on both strands of the duplex is 
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not guaranteed. The specific structural elements themselves are not determined at 
this time; however, the most poorly bound DNAs tend to have very few G 
residues in their sequence and the least amount of cleavage. Although, the 
converse is not necessarily true. The high binding specificity of hairpin DNA 2 is 
lacking in cleavage sites, achieving only three on the 5ʹ-arm and four on the 3ʹ-
arm (Figure 2.4).  
DNA 2 had four strong cleavage sites of the type 5ʹ-GPy-3ʹ and the 
highest binding specificity (97%). The strongest relative cleavage occurred at 5ʹ-
GT13-3. This efficient cleavage at few sites on both strands while offering the 
highest binding specificity indicates a predilection for BLM to preferentially bind 
a short sequence motif strongly and cleave preferentially at those sites. It is also 
possible, however, that many sites on the hairpin were bound, but the hairpin 
DNA 2 was simply not cleaved at those sites. 
 DNA 5 provided a stark contrast to the other DNAs studied. It contains no 
canonical sites for cleavage, but was still cleaved by BLM 13 times on the 5ʹ-arm 
(Figure 2.7B). The BLM mediated cleavages occurred in both the randomized and 
invariant regions. The binding specificity of DNA 5 was 90%, which is relatively 
high, but not the greatest measured. The coincidence of a high binding specificity 
and a great number of cleavage sites could indicate that BLM responds to the 
tertiary structure assumed by this hairpin DNA where it is able to make many 
contacts with the molecule. Unlike DNA 2 (Figure 2.4), which had comparatively 
few sites of cleavage and a higher binding specificity, DNA 5 (Figure 2.7) may 
bind less tightly, allowing for interaction sufficient for cleavage activity, but 
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indiscriminate enough that BLM binding and cleavage events occur at many 
points on the DNA molecule. 
The idea that BLM identifies a global DNA structure is supported by the 
cleavage pattern demonstrated by the 3′-32P end labeled DNA 1 (Figure 2.3B). 
More cleavage appeared in the invariant region of this DNA than in the others 
tested. BLM may recognize the minor groove of this hairpin DNA more readily in 
the invariant than in the randomized region. Precisely what these recognition 
elements are is uncertain, but if the randomized region is lacking in preferred 
sites, the BLM molecule may bind readily to the deeper minor groove of the AT-
rich region such that its opportunity to cleave within that region is enhanced 
compared to the 8-bp randomized region. Also of note is that thymidine was the 
preferred nucleoside to cleave in the randomized region, following the usual 
preference of BLM to oxidatively release pyrimidine bases and base propenals. 
The analysis of Fe·BLM cleavage of this specially selected library of 
hairpin DNAs shows that binding is an important step in the determination of the 
DNA sequences cleaved by BLM. This library is rich in non-traditional cleavage 
sites and the 64-nt hairpin DNAs were greatly preferred over the 16-nt hairpin 
DNA as a substrate for binding. The hairpin DNAs also offer insights into the 
strand selectivity of BLM, where a molecule can be a substrate for cleavage, but 
one strand is preferred greatly over the other, as in the G content of one arm of the 
hairpin DNA versus the other. 
The development and characterization of this library through cleavage 
reactions represents an important step forward in delineating the relationship 
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between binding and cleavage to binding of DNA. These results, in concert with 
preliminary double-stranded damage assays indicate quite strongly that binding 
specificity may be a major determinant in how BLM acts in vivo. The exact DNA 
structures and precise motifs that BLM prefers, however, are still elusive and 
worthy of further study. Possible avenues for future work include employing a 
more iterative SELEX-type procedure along with a larger randomized region for 
binding by BLM. 
 The method developed for studying the dsDNA damage inflicted by BLM 
A5 on DNA 8 is convenient for the identifying sites of dsDNA, but is a poor 
method for characterization of ssDNA:dsDNA damage ratios (Figures 2.10, 13 
and 14). Both the sites of cleavage and the rates at which BLM A5 produces either 
ssDNA damage or dsDNA are of interest. However this method is only applicable 
to finding the sites of dsDNA damage.  
 The finding that many of these strongly bound hairpin DNAs are subject 
to dsDNA damage at multiple sites would offer more insight into the importance 
of binding selectivity to BLM–mediated cleavage. The exact sequence motif(s) 
and global structures that facilitate the production of dsDNA damage are certainly 
worthy of further study. Direct and unambiguous measurement of the extent of ds 
versus ss damage in such small DNAs presents a technical challenge that will 
require the development of another assay system.  
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Experimental Procedures  
Terminal deoxynucleotidyl transferase was purchased from Roche 
Applied Science. T4 polynucleotide kinase was obtained from New England 
Biolabs. All synthetic oligonucleotides, purified by ion exchange, were purchased 
from Integrated DNA Technologies. Radionucleotides were purchased from 
Perkin Elmer Life Sciences. BLM A5 solutions were dissolved in water 
immediately prior to use. Fe(NH4)2(SO4)2·6H2O was purchased from Sigma 
Aldrich Chemicals and used to prepare fresh Fe
2+
 solutions immediately prior to 
use. Chelex 100 was purchased from Sigma Aldrich and used to remove 
adventitious Fe
2+
 from solutions prior to experiments. 
 Polyacrylamide gel electrophoresis was carried out in 90 mM Tris-borate 
buffer, pH 8.3, containing 5 mM EDTA. Cleavage sites were confirmed by 
comparison with the reaction products obtained by the Maxam-Gilbert G lane, 
Maxam-Gilbert G + A
67
 and cytidine specific sequencing protocols.
68
 Analysis of 
the polyacrylamide gels was carried out by phosphorimager analysis using a 
Molecular Dynamics Storm 820 Phosphorimager.  
3ʹ-32P End Labeling and Purification of 64-nt Hairpin DNAs  
3ʹ-32P end labeling was carried out by combining 10 pmol of the 
appropriate 64-nt hairpin DNA, 0.06 mCi [α-32P]cordycepin (specific activity 
5000 Ci (185 TBq)/mmol) and 400 units of recombinant terminal transferase in 40 
µL (total volume) of 25 mM Tris-HCl, pH 6.6, containing 200 mM potassium 
cacodylate, 2.5 mM CoCl2 and 0.25 mg/mL BSA. The reaction mixture was 
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incubated at 37 °C for 1 h. The 3ʹ-32P end labeled 64-nt hairpin DNA was purified 
by 16% polyacrylamide gel electrophoresis at 1800 V for 2.5 h. 
5ʹ-32P End Labeling and Purification of Hairpin DNA 
 Ten pmol of 64-nt hairpin DNA was 5ʹ-32P end labeled by incubation with 
20 units of T4 polynucleotide kinase and 0.06 mCi [γ-32P]ATP (specific activity 
6000 Ci (222 TBq)/mmol) in 50 μL (total volume) of 70 mM Tris-HCl buffer, pH 
7.6, containing 10 mM MgCl2 and 5 mM dithiothrietol. The reaction mixture was 
incubated at 37 °C for 1 h followed by heat inactivation of the enzyme at 65 °C 
for 20 min. The 5ʹ-32P end labeled 64-nt hairpin DNA was purified by 16% 
polyacrylamide gel electrophoresis at 1800 V for 2.5 h.  
Sequence-Selective Cleavage of Radiolabeled Hairpin DNA by BLM A5 
A sample of 5′ or 3′-32P end labeled hairpin DNA (50,000 cpm) was 
treated with the appropriate concentrations of Fe
2+
 and BLM solutions in 5 μL 
(total volume) of 10 mM Na cacodylate buffer, pH 7.0. Reactions were incubated 
at 25 °C for 30 min followed by removal of the supernatant under diminished 
pressure. Ten µL of denaturing gel loading buffer containing 98% formamide, 2 
mM EDTA, 0.25% (w/v) bromophenol blue and 0.25% (w/v) xylene cyanol was 
added to the DNA pellet. The resulting solution was heated at 90 °C for 10 min, 
followed by chilling on ice. Five microliters of each sample was loaded onto a 
denaturing gel (16% polyacrylamide, 7 M urea) and run at 50 W for 2.5 h. Gels 
were visualized using a phosphorimager. 
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Polyacrylamide Electrophoresis of 64-nt Hairpin DNAs for dsDNA Damage 
A sample of 
32
P end labeled hairpin DNA (50,000 cpm) was treated with 
the appropriate concentrations of Fe
2+
 and BLM solutions in 5 μL (total volume) 
of 10 mM Na cacodylate buffer, pH 7.0 containing 2 mM MgCl2. The reactions 
were quenched by addition of 1 µL native gel loading buffer containing 40% 
(w/v) sucrose, 0.25% (w/v) bromophenol blue and 0.25% (w/v) xylene cyanol and 
immediately electrophoresed on a native polyacrylamide gel (20% 
polyacrylamide) incubated at 4 °C run at 240 V for 18 h. 
 After visualization via phosphorimager, relevant bands were excised from 
the gel and incubated at 37 °C in 1 mL of ddH2O for 18 h. After decantation, the 
sample was concentrated to ~5 µL under diminished pressure.  Ten µL of 
denaturing gel loading buffer containing 98% formamide, 2 mM EDTA, 0.25% 
(w/v) bromophenol blue and 0.25% (w/v) xylene cyanol was added to the 
resulting solution. The mixture was heated at 90 °C for 10 min and the sample 
and an appropriate Maxam-Gilbert sequencing ladder were loaded onto a 
denaturing gel (16% polyacrylamide, 7 M urea) and run at 50 W for 2.5 h. The gel 
was visualized using a phosphorimager. 
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